Battling cancer has always been about timing, catch it early enough and you are better positioned for victory. Unfortunately traditional diagnosis is dependent on the physical discovery of cancerous…
Biotech
Closing the Diabetic Loop Before we get into this week’s sector roundup, let’s talk about diabetes. I am a sucker for sweets, so much so that I was diagnosed…
Repare Therapeutics (RPTX) is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its…
Remember that there’s always an alternative. You’ll notice the bitcoin is back and prominent in the featured image. It’s down and heavily so, but that’s probably not going to…
Miraculous Microchip Yes, you read that right. Earlier this week, German Aldana Zuniga got behind the wheel of an 850 horsepower NASCAR Cup race car. At first glance, this…
A Pain in the Behind I don’t fear a lot of things. Well, other than spiders, heights, and being stabbed. However, more than anything I have always been afraid…
Evoke Pharma is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets GIMOTI, a nasal…
Smart Watch, Healthy Heart There was an opportunity for a pun in the headline and I took it. In this week’s sector roundup, we are going to be…
Feliz Navidea $29.79M Market Capitalization Navidea Biopharmaceuticals Inc. (NAVB.NYSE) announced today that it has received regulatory approval in India for its Lymphoaim, also referred to as Lymphoseek in the…
A big mover in Clarus Therapeutics (CRXT) today which saw the stock at one point up over 70%! The stock sees an average volume of 1,300,000 shares. At time…